FDA OKs marketing Plan B to 17-year-olds
The Food and Drug administration announced today that it has notified the maker of Plan B, the morning-after pill, permitting it to market the drug to 17-year-olds without a prescription. The move follows a March ruling by a federal judge that the FDA's earlier decision requiring those younger than 18 to consult with a doctor was not justified on safety grounds.
Here's a recent article on the Plan B issue. And here's more info plus what others are saying about this latest move:
The FDA statement and a page detailing the drug's regulatory history;
Center for Reproductive Rights, which sued the FDA on its delay to grant over-the-counter access of Plan B;
Family Research Council, which opposes the judge's ruling;
An Associated Press article on the FDA's latest move;
-- Rosie Mestel
